Sources | Names Used |
---|---|
CTRPv2 | BRD-K16147474 |
PharmacoGx | BRD-K16147474 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CBL | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
mRNA | VWA9 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
mRNA | LARP1B | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
mRNA | MROH1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.06 |
mRNA | C2CD4D | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
mRNA | ZNF688 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
mRNA | EGR3 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.06 |
mRNA | LYSMD4 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
mRNA | ATP5A1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
mRNA | SRP14 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |